Literature DB >> 7460369

Sporadic occurrence of Duchenne muscular dystrophy: evidence for new mutation.

C T Caskey, R L Nussbaum, L C Cohan, L Pollack.   

Abstract

The mechanism of inheritance of sporadically occurring Duchenne muscular dystrophy has been investigated in 42 families, using carrier detection methods and genetic evaluation. Our studied find that serum CPK detects 72% of female carriers of DMD. Quantitative LDH and/or its isozymes were not found to be a useful means of carrier detection, as reported by Roses et al. (1977). Employing family pedigree data and CPK carrier testing, we determined by Bayesian methods the probability that the mother and maternal grandmother in these families were DMD carriers. These studies revealed 23 families (Category I) with no evidence for DMD carriers, 11 families (Category II) in which the mother was found to be a carrier, and 3 families (Category III) in which both mother and maternal grandmother were found to be carriers. Nineteen of the 42 families have a greater than 83% probability that the sporadic DMD case arose by mutation in a maternal gamete. This finding is in good agreement with the theoretically expected 1/3 of DMD cases arising by new mutation.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7460369     DOI: 10.1111/j.1399-0004.1980.tb02293.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  13 in total

Review 1.  Duchenne muscular dystrophy animal models for high-throughput drug discovery and precision medicine.

Authors:  Nalinda B Wasala; Shi-Jie Chen; Dongsheng Duan
Journal:  Expert Opin Drug Discov       Date:  2020-01-30       Impact factor: 6.098

Review 2.  Canine models of Duchenne muscular dystrophy and their use in therapeutic strategies.

Authors:  Joe N Kornegay; Janet R Bogan; Daniel J Bogan; Martin K Childers; Juan Li; Peter Nghiem; David A Detwiler; C Aaron Larsen; Robert W Grange; Ratna K Bhavaraju-Sanka; Sandra Tou; Bruce P Keene; James F Howard; Jiahui Wang; Zheng Fan; Scott J Schatzberg; Martin A Styner; Kevin M Flanigan; Xiao Xiao; Eric P Hoffman
Journal:  Mamm Genome       Date:  2012-01-05       Impact factor: 2.957

Review 3.  Dystrophin-deficient large animal models: translational research and exon skipping.

Authors:  Xinran Yu; Bo Bao; Yusuke Echigoya; Toshifumi Yokota
Journal:  Am J Transl Res       Date:  2015-08-15       Impact factor: 4.060

Review 4.  Duchenne muscular dystrophy: pathogenetic aspects and genetic prevention.

Authors:  H Moser
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

5.  Duchenne muscular dystrophy. Frequency of sporadic cases.

Authors:  G A Danieli; G Barbujani
Journal:  Hum Genet       Date:  1984       Impact factor: 4.132

6.  The genetic status of mothers of isolated cases of Duchenne muscular dystrophy.

Authors:  R J Lane; M Robinow; A D Roses
Journal:  J Med Genet       Date:  1983-02       Impact factor: 6.318

7.  Estimation of the male to female ratio of mutation rates from the segregation of X-chromosomal DNA haplotypes in Duchenne muscular dystrophy families.

Authors:  C R Müller; T Grimm
Journal:  Hum Genet       Date:  1986-10       Impact factor: 4.132

8.  Prenatal diagnosis of Duchenne muscular dystrophy: prospective linkage analysis and retrospective dystrophin cDNA analysis.

Authors:  P A Ward; J F Hejtmancik; J A Witkowski; L L Baumbach; S Gunnell; J Speer; P Hawley; U Tantravahi; C T Caskey
Journal:  Am J Hum Genet       Date:  1989-02       Impact factor: 11.025

9.  The cooperative international neuromuscular research group Duchenne natural history study: glucocorticoid treatment preserves clinically meaningful functional milestones and reduces rate of disease progression as measured by manual muscle testing and other commonly used clinical trial outcome measures.

Authors:  Erik K Henricson; R Ted Abresch; Avital Cnaan; Fengming Hu; Tina Duong; Adrienne Arrieta; Jay Han; Diana M Escolar; Julaine M Florence; Paula R Clemens; Eric P Hoffman; Craig M McDonald
Journal:  Muscle Nerve       Date:  2013-05-06       Impact factor: 3.217

10.  Somatic mosaicism for Duchenne dystrophy: evidence for genetic normalization mitigating muscle symptoms.

Authors:  Akanchha Kesari; Robert Neel; Lynne Wagoner; Brennan Harmon; Christopher Spurney; Eric P Hoffman
Journal:  Am J Med Genet A       Date:  2009-07       Impact factor: 2.802

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.